Central effects of selective NK 1 and NK 3 tachykinin receptor agonists on two models of experimentally-induced colitis in rats

By Improta G.   Carpino F.   Petrozza V.   Guglietta A.   Tabacco A.   Broccardo M.  

Peptides, Vol. 24, Iss. 6, 2003-06 ,pp. : 903-911

Elsevier

Access to resources Recommend Favorite

Metabolism, pharmacokinetics and excretion of a potent tachykinin NK1 receptor antagonist (CP-122,721) in rat: Characterization of a novel oxidative pathway

By Kamel A.   Davis J.   Potchoiba M. J.   Prakash C.  

Xenobiotica, Vol. 36, Iss. 2-3, 2006-02 ,pp. : 235-258

Informa Healthcare

Access to resources Recommend Favorite

Characterization of 3HMEN 11420, a Novel Glycosylated Peptide Antagonist Radioligand of the Tachykinin NK2 Receptor

By Renzetti A.R.   Catalioto R.M.   Criscuoli M.   Cucchi P.   Lippi A.   Guelfi M.   Quartara L.   Maggi C.A.  

Biochemical and Biophysical Research Communications, Vol. 248, Iss. 1, 1998-07 ,pp. : 78-82

Elsevier

Access to resources Recommend Favorite

Bach1, a heme-dependent transcription factor, reveals presence of multiple heme binding sites with distinct coordination structure

By Hira Shusuke  

IUBMB Life, Vol. 59, Iss. 8-9, 2007-01 ,pp. : 542-551

Informa Healthcare

Access to resources Recommend Favorite

Functionally-distinct proton-binding in HERG suggests the presence of two binding sites

By Bett Glenma   Rasmusson Randall  

Cell Biochemistry and Biophysics, Vol. 39, Iss. 3, 2003-10 ,pp. : 183-193

Humana Press, Inc

Access to resources Recommend Favorite